Study to Evaluate Induction of HBV Virus Neutralizing Antibodies Using VVX001
Clinical trial NCT03625934 · UNKNOWN
Trial details
- NCT number
- NCT03625934
- Sponsor
- Viravaxx AG
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-06
- Primary completion
- 2023-09-30
- Enrollment
- 84
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.